Literature DB >> 8789454

A gene responsible for a sensorineural nonsyndromic recessive deafness maps to chromosome 2p22-23.

H Chaïb1, C Place, N Salem, S Chardenoux, C Vincent, J Weissenbach, E El-Zir, J Loiselet, C Petit.   

Abstract

The recessive mode of transmission accounts for approximately 75% of inherited non syndromic deafness cases. We have previously designed the conditions for linkage studies of this highly heterogeneous disorder [Guilford et al. (1994) Nature Genet. 6, 24-28]. Here, using a similar approach, we have studied the segregation of a gene responsible for congenital, profound and fully penetrant sensorineural deafness in a consanguineous family living in an isolated region of Lebanon. A maximum lod score of 8.03 (theta = 0.00) was detected with a new polymorphic marker, AFMa052yb5 (D2S2144). Observed recombinants and homozygosity mapping define a maximum interval of 2 cM for this gene, DFNB6, which lies between AFMb346ye5 (a new polymorphic marker) (D2S2303) and AFM254vc9 (D2S174) on chromosome 2p22-23.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789454     DOI: 10.1093/hmg/5.1.155

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

1.  Inner ear defect similar to Alport's syndrome in the glomerulosclerosis mouse model Mpv17.

Authors:  A M Meyer zum Gottesberge; A Reuter; H Weiher
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Pendred syndrome: evidence for genetic homogeneity and further refinement of linkage.

Authors:  E Gausden; B Coyle; J A Armour; R Coffey; A Grossman; G R Fraser; R M Winter; M E Pembrey; P Kendall-Taylor; D Stephens; L M Luxon; P D Phelps; W Reardon; R Trembath
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

3.  A review of the diverse genetic disorders in the Lebanese population: highlighting the urgency for community genetic services.

Authors:  Ghunwa Nakouzi; Khalil Kreidieh; Soha Yazbek
Journal:  J Community Genet       Date:  2014-09-27

4.  An autosomal recessive nonsyndromic-hearing-loss locus identified by DNA pooling using two inbred Bedouin kindreds.

Authors:  D A Scott; R Carmi; K Elbedour; S Yosefsberg; E M Stone; V C Sheffield
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

5.  A new locus for non-syndromal, autosomal recessive, sensorineural hearing loss (DFNB16) maps to human chromosome 15q21-q22.

Authors:  D A Campbell; D P McHale; K A Brown; L M Moynihan; M Houseman; G Karbani; G Parry; A H Janjua; V Newton; L al-Gazali; A F Markham; N J Lench; R F Mueller
Journal:  J Med Genet       Date:  1997-12       Impact factor: 6.318

6.  Genetic linkage of hereditary gingival fibromatosis to chromosome 2p21.

Authors:  T C Hart; D Pallos; D W Bowden; J Bolyard; M J Pettenati; J R Cortelli
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

7.  Screening mutations of OTOF gene in Chinese patients with auditory neuropathy, including a familial case of temperature-sensitive auditory neuropathy.

Authors:  Da-Yong Wang; Yi-Chen Wang; Dominique Weil; Ya-Li Zhao; Shao-Qi Rao; Liang Zong; Yu-Bin Ji; Qiong Liu; Jian-Qiang Li; Huan-Ming Yang; Yan Shen; Cindy Benedict-Alderfer; Qing-Yin Zheng; Christine Petit; Qiu-Ju Wang
Journal:  BMC Med Genet       Date:  2010-05-26       Impact factor: 2.103

8.  A second middle eastern kindred with autosomal recessive non-syndromic hearing loss segregates DFNB9.

Authors:  S M Leal; F Apaydin; C Barnwell; M Iber; T Kandogan; M Pfister; U Braendle; O Cura; M Schwalb; H P Zenner; E Vitale
Journal:  Eur J Hum Genet       Date:  1998 Jul-Aug       Impact factor: 4.246

Review 9.  Autosomal recessive nonsyndromic deafness genes: a review.

Authors:  Duygu Duman; Mustafa Tekin
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

Review 10.  Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.

Authors:  Michelle L Hastings; John V Brigande
Journal:  Hear Res       Date:  2020-03-05       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.